As AD progresses, the likelihood of TREM2 loss of function increases; this process is thought to support a protective role in AD because DEGs regulated by TREM2 would participate in the immune response, anti-apoptotic signaling, and changes in the microglial cytoskeleton upon TREM2 activation [4]. This evidence concerns the gene TREM2 and Alzheimer disease.